NCT06611826 2024-09-25
GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC
Zhejiang Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
12 trialsNCT05514275 2022-08-24
Radiotherapy Combined With Endostatin and Capecitabine for NPC
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT02636231 2021-02-03
Endostar for Locally Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT03989830 2020-10-23
SLICER
Peking University
Phase 2 Unknown
NCT03932266 2019-04-30
Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT02902432 2019-01-31
A Trial of Endostar in Patients With Carcinoma of the Head and Neck
China International Medical Foundation
Phase 2 Unknown
NCT02590133 2017-12-22
A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
Sun Yat-sen University
Phase 2 Unknown
NCT02907710 2016-09-20
Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 3 Unknown
NCT02630264 2015-12-15
E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Guangzhou Double Bioproducts Co., Ltd
Phase 3 Unknown
NCT01915134 2015-01-01
Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT01612286 2014-02-19
Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT01347424 2013-12-09
Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography
Sun Yat-sen University
Phase 2 Unknown